8-K/A

FORM 8-K/A AMENDED CURRENT REPORT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: May 29, 2020
Period of Report: May 14, 2020
Accession Number: 0001078782-20-000386

View Document ↗ View on SEC.gov ↗